Instructions for Delufen nasal spray bottle with sprayer 20 ml
Warehouse
active ingredients: 100 ml of solution contain: Sinapis nigra D2 1 ml, Euphorbium D6 10 ml, Pulsatilla D6 10 ml, Luffa D12 10 ml, Mercurius bijodatus D12 10 ml;
Excipients: isotonic sodium chloride solution, benzalkonium chloride.
Dosage form
Nasal spray.
Main physicochemical properties: clear, colorless, odorless liquid.
Pharmacotherapeutic group
A complex homeopathic preparation.
Pharmacological properties
DELUFEN®, nasal spray, thanks to its complex anti-inflammatory, anti-allergic, reparative and protective effect on the mucous membrane of the nose and paranasal sinuses, effectively treats rhinitis regardless of the cause (viral, bacterial, vasomotor or allergic). Quickly eliminates inflammation and swelling, without causing irritation or a feeling of dryness in the nasal cavity. Frees the nasal passages and sinuses from mucus. Reduces the risk of developing purulent complications of acute catarrhal rhinosinusitis.
At the same time, the drug has a pronounced antiallergic effect: it eliminates itching, swelling, nasal congestion and rhinorrhea of allergic origin, including in hay fever and hay fever. The drug reduces the sensitivity of mucous membranes to various irritants (odors, tobacco smoke, changes in ambient air temperature) and allergens (plant pollen, household dust, wool).
Does not cause addiction or weakening of the therapeutic effect, even with prolonged use.
In patients with manifestations of chronic atrophic rhinitis, such as dryness of the nasal mucosa, increased vulnerability and bleeding of the mucous membrane, the drug restores the function of goblet cells, nutrition and structure of the nasal mucosa. Moisturizes the mucous membrane, relieves dryness in the nose and crusts. Promotes the healing processes of the mucous membrane, restores its protective function, normal nasal breathing and sense of smell.
The drug has a direct antimicrobial effect, strengthens local immunity and restores the normal biocenosis of the nasopharyngeal mucosa.
Indication
Local treatment of acute and chronic rhinitis (rhinitis, rhinosinusitis) of various etiologies (infectious, viral or bacterial, vasomotor, allergic, including hay fever, pollinosis); inflammation of the auditory tube (eustachitis).
Contraindication
Hypersensitivity to any of the components of the drug.
Interaction with other medicinal products and other types of interactions
No clinically significant interactions with other pharmacological agents have been established.
The drug can be combined with any medications and treatment methods.
Application features
In case of concomitant thyroid diseases, the drug should not be used without prior consultation with a doctor.
The vial with the drug is not under pressure, so it does not require special safety measures when used.
At the beginning of treatment, a short-term slight increase in secretion in the form of serous-mucous discharge from the nose is possible, which indicates the effect of the drug, effective drainage of the paranasal sinuses, nasal cavity and their liberation from accumulated mucus. This is a favorable sign and does not require discontinuation or dose adjustment of the drug.
Since DELUFEN®, nasal spray, contains plant and other natural ingredients, a slight change in the transparency or color of the solution may occur during storage, which does not lead to a decrease in the quality and effectiveness of the drug.
DELUFEN®, nasal spray, contains benzalkonium chloride, which when applied externally may cause irritation and skin reactions.
Use during pregnancy or breastfeeding
The drug has a local effect. Information on any risk to the fetus and child in case of use of the drug during pregnancy and breastfeeding has not yet been registered, therefore it can be used during pregnancy or breastfeeding.
Ability to influence reaction speed when driving vehicles or other mechanisms
The drug does not affect the ability to drive vehicles and other mechanical devices.
Method of administration and doses
Adults and children over 12 years of age: at the beginning of treatment, apply 2 sprays into each nasal passage every half hour to an hour (maximum 8 times a day).
Children aged 3 to 12 years: at the beginning of treatment, apply 1 injection into each nasal passage every half hour to an hour (maximum 8 times a day).
After the condition improves, apply 3-4 times a day.
1 injection ≈ 120 mg.
Duration of treatment.
In chronic diseases, the course of treatment may be 4 weeks.
If necessary, the course of treatment can be repeated.
Method of application:
Remove the protective cap.
Before using the drug for the first time, you must press several times until a spray appears.
Insert the spray into the nostril and inject.
Each time after use, it is necessary to wipe the sprayer and close it.
Overdose. No cases of overdose have been registered.
Adverse reactions. Allergic reactions may occur in individuals with hypersensitivity to any component of the drug. After using the drug, increased salivation may be observed. Due to the presence of benzalkonium chloride in the composition of the drug, bronchospasm is possible.
There is no information on the frequency of adverse reactions.
Expiration date
5 years.
Do not use the product after the expiry date stated on the packaging. The product is suitable for use within 2 months from the moment the bottle is first opened.
Storage conditions
Store in a tightly closed bottle, in the original cardboard packaging, at a temperature not exceeding 25 °C, out of the reach of children.
Packaging
Plastic bottles of 20 ml or 30 ml with a plastic sprayer in a cardboard box.
Vacation category
Without a prescription.
Producer
Richard Bittner AG.
Location of the manufacturer and its business address
Ossiacherstrasse 7, A-9560 Feldkirchen, Austria.
